Lung carcinoma tissue microarray with normal lung tissue, single core per case. Pathology grade, TNM Classification and Clinical Stages ( AJCC 8th edition) information available. Replacing LC811a.
- 34 cases of adenocarcinoma
- 13 cases of squamous cell carcinoma
- 23 cases of small cell carcinoma
- 10 cases of normal lung tissue
Price
$255.00
Catalogue No | RLN811b |
Species | Human |
Fixative | Formalin |
Total Cases | 80 |
Total Cores | 80 |
Core Diameter | 1.5 mm |
Section Thickness | 5 µm |
Storage | Short term RT; Long term 4ºC |
Usage | For research use only. Designed for Immunohistochemistry (IHC) and In Situ Hybridization (ISH) |
A | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU |
B | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU |
C | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU |
D | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU |
E | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU |
F | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU |
G | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU |
H | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU |
N | N/ |
Showing All Data
No. | Map ID | Age | Sex | Organ | Pathology Diagnosis | Grade | TNM | Stage | Type |
---|---|---|---|---|---|---|---|---|---|
1 | A1 | 48 | M | Lung | Adenocarcinoma | 2 | T2aN1M0 | IIB | Malignant |
2 | A2 | 54 | F | Lung | Adenocarcinoma | 2 | T2aN1M0 | IIB | Malignant |
3 | A3 | 50 | F | Lung | Mucinous adenocarcinoma | 1 | T3N0M0 | IIB | Malignant |
4 | A4 | 70 | M | Lung | Adenocarcinoma | 2 | T1cN0M0 | IA3 | Malignant |
5 | A5 | 65 | F | Lung | Adenocarcinoma | 2 | T3N2M0 | IIIB | Malignant |
6 | A6 | 55 | M | Lung | Adenocarcinoma | 2 | T2aN0M0 | IB | Malignant |
7 | A7 | 56 | F | Lung | Papillary adenocarcinoma | 2 | T2N0M0 | IB | Malignant |
8 | A8 | 77 | M | Lung | Papillary adenocarcinoma | 2 | T2aN0M0 | IB | Malignant |
9 | A9 | 62 | M | Lung | Adenocarcinoma | 2 | T2aN0M0 | IB | Malignant |
10 | A10 | 71 | F | Lung | Adenocarcinoma | 2 | T2bN1M0 | IIB | Malignant |
11 | B1 | 35 | F | Lung | Adenocarcinoma | 2 | T2aN1M0 | IIB | Malignant |
12 | B2 | 59 | M | Lung | Adenocarcinoma | 2 | T1cN3M0 | IIIB | Malignant |
13 | B3 | 43 | F | Lung | Adenocarcinoma | 2 | T2aN2M0 | IIIA | Malignant |
14 | B4 | 58 | M | Lung | Solid adenocarcinoma | 3 | T2bN0M0 | IIA | Malignant |
15 | B5 | 43 | M | Lung | Solid adenocarcinoma | 3 | T2bN0M0 | IIA | Malignant |
16 | B6 | 49 | F | Lung | Adenocarcinoma | 2 | T1bN1M0 | IIB | Malignant |
17 | B7 | 75 | M | Lung | Adenocarcinoma | 3 | T2aN0M0 | IB | Malignant |
18 | B8 | 65 | M | Lung | Solid adenocarcinoma | 3 | T2bN2M0 | IIA | Malignant |
19 | B9 | 53 | M | Lung | Solid adenocarcinoma | 3 | T2bN0M0 | IIA | Malignant |
20 | B10 | 67 | M | Lung | Adenocarcinoma | 3 | T3N0M0 | IIB | Malignant |
21 | C1 | 57 | M | Lung | Adenocarcinoma | 3 | T2bN0M0 | IIA | Malignant |
22 | C2 | 82 | M | Lung | Adenocarcinoma | 3 | T2aN1M0 | IIB | Malignant |
23 | C3 | 52 | F | Lung | Adenocarcinoma | 3 | T3N1M0 | IIIA | Malignant |
24 | C4 | 60 | F | Lung | Invasive adenocarcinoma | - | T2aN0M0 | IB | Malignant |
25 | C5 | 54 | M | Lung | Papillary adenocarcinoma | 2 | T3N1M0 | IIIA | Malignant |
26 | C6 | 47 | M | Lung | Invasive adenocarcinoma | - | T2N0M0 | IB | Malignant |
27 | C7 | 57 | F | Lung | Papillary adenocarcinoma | 2 | T3N0M0 | IIB | Malignant |
28 | C8 | 56 | F | Lung | Papillary adenocarcinoma | 2 | T2N0M0 | IB | Malignant |
29 | C9 | 56 | F | Lung | Papillary adenocarcinoma | 2 | T3N1M0 | IIIA | Malignant |
30 | C10 | 67 | M | Lung | Lepidic predominant adenocarcinoma | - | T2N0M0 | IB | Malignant |
31 | D1 | 50 | F | Lung | Lepidic predominant adenocarcinoma | - | T3N0M0 | IIB | Malignant |
32 | D2 | 48 | F | Lung | Lepidic predominant adenocarcinoma | - | T2N0M0 | IB | Malignant |
33 | D3 | 67 | M | Lung | Lepidic predominant adenocarcinoma | - | T2N1M0 | IIB | Malignant |
34 | D4 | 75 | F | Lung | Lepidic predominant adenocarcinoma | - | T2N1M0 | IIB | Malignant |
35 | D5 | 68 | M | Lung | Squamous cell carcinoma | 1 | T4N0M0 | IIIA | Malignant |
36 | D6 | 68 | M | Lung | Squamous cell carcinoma | 1 | T3N0M0 | IIB | Malignant |
37 | D7 | 67 | M | Lung | Squamous cell carcinoma | 3 | T2aN0M0 | IB | Malignant |
38 | D8 | 74 | M | Lung | Squamous cell carcinoma | 2 | T3N0M0 | IIB | Malignant |
39 | D9 | 56 | M | Lung | Squamous cell carcinoma | 2 | T3N2M0 | IIIB | Malignant |
40 | D10 | 65 | M | Lung | Squamous cell carcinoma | 2 | T2bN0M0 | IIA | Malignant |
41 | E1 | 69 | M | Lung | Squamous cell carcinoma | 3 | T2aN0M0 | IB | Malignant |
42 | E2 | 51 | F | Lung | Squamous cell carcinoma | 3 | T2bN1M0 | IIB | Malignant |
43 | E3 | 48 | M | Lung | Squamous cell carcinoma | 3 | T2aN0M0 | IB | Malignant |
44 | E4 | 62 | M | Lung | Squamous cell carcinoma | 3 | T3N1M0 | IIIA | Malignant |
45 | E5 | 66 | M | Lung | Squamous cell carcinoma (tumor necrosis) | * | T3N1M0 | IIIA | Malignant |
46 | E6 | 54 | M | Lung | Squamous cell carcinoma | 3 | T3N0M0 | IIB | Malignant |
47 | E7 | 64 | M | Lung | Squamous cell carcinoma | 3 | T3N1M0 | IIIA | Malignant |
48 | E8 | 43 | F | Lung | Small cell carcinoma | - | T2bN0M0 | IIA | Malignant |
49 | E9 | 52 | F | Lung | Small cell carcinoma | - | T2bN1M0 | IIB | Malignant |
50 | E10 | 61 | M | Lung | Small cell carcinoma | - | T4N1M0 | IIIA | Malignant |
51 | F1 | 44 | F | Lung | Small cell carcinoma | - | T2aN0M0 | IB | Malignant |
52 | F2 | 61 | M | Lung | Small cell carcinoma | - | T2aN0M0 | IB | Malignant |
53 | F3 | 31 | F | Lung | Small cell carcinoma | - | T2bN0M0 | IIA | Malignant |
54 | F4 | 51 | M | Lung | Small cell carcinoma | - | T4N1M0 | IIIA | Malignant |
55 | F5 | 53 | M | Lung | Small cell carcinoma | - | T2bN0M0 | IIA | Malignant |
56 | F6 | 37 | F | Lung | Small cell carcinoma | - | T2bN0M0 | IIA | Malignant |
57 | F7 | 53 | F | Lung | Small cell carcinoma | - | T1cN2M0 | IIIA | Malignant |
58 | F8 | 64 | M | Lung | Small cell carcinoma | - | T3N1M0 | IIIA | Malignant |
59 | F9 | 60 | M | Lung | Small cell carcinoma | - | T2bN1M0 | IIB | Malignant |
60 | F10 | 33 | M | Lung | Small cell carcinoma | - | T2bN2M0 | IIIA | Malignant |
61 | G1 | 55 | M | Lung | Small cell carcinoma | - | T4N1M0 | IIIA | Malignant |
62 | G2 | 36 | M | Lung | Small cell carcinoma | - | T2aN2M0 | IIIA | Malignant |
63 | G3 | 47 | M | Lung | Small cell carcinoma | - | T2aN1M0 | IIB | Malignant |
64 | G4 | 51 | F | Lung | Small cell carcinoma | - | T2aN1M0 | IIB | Malignant |
65 | G5 | 47 | F | Lung | Small cell carcinoma | - | T3N0M0 | IIB | Malignant |
66 | G6 | 56 | M | Lung | Small cell carcinoma | - | T3N1M0 | IIIA | Malignant |
67 | G7 | 41 | M | Lung | Small cell carcinoma | - | T4N2M0 | IIIB | Malignant |
68 | G8 | 49 | M | Lung | Small cell carcinoma | - | T2aN0M0 | IIB | Malignant |
69 | G9 | 60 | M | Lung | Small cell carcinoma | - | T2aN0M0 | IIB | Malignant |
70 | G10 | 36 | M | Lung | Small cell carcinoma | - | T2bN1M0 | IIB | Malignant |
71 | H1 | 40 | F | Lung | Normal Lung Tissue | - | - | - | Normal |
72 | H2 | 23 | M | Lung | Normal Lung Tissue | - | - | - | Normal |
73 | H3 | 33 | M | Lung | Normal Lung Tissue | - | - | - | Normal |
74 | H4 | 30 | M | Lung | Normal Lung Tissue | - | - | - | Normal |
75 | H5 | 16 | F | Lung | Normal Lung Tissue | - | - | - | Normal |
76 | H6 | 30 | M | Lung | Normal Lung Tissue | - | - | - | Normal |
77 | H7 | 21 | F | Lung | Normal Lung Tissue | - | - | - | Normal |
78 | H8 | 2 | F | Lung | Normal Lung Tissue | - | - | - | Normal |
79 | H9 | 24 | M | Lung | Normal Lung Tissue | - | - | - | Normal |
80 | H10 | 48 | M | Lung | Normal Lung Tissue | - | - | - | Normal |
N/A | N/A | N/A | N/A | N/A | _pheochromocytoma_ Tissue Marker | N/A | N/A | N/A | N/A |